Vijaypd Ceutical
Key Fundamentals
SMEPharmacy RetailRetailPrice-based figures as of 13 Oct 2026, 15:20 IST · TTM
Peer Comparison
Industrials › Retail › Pharmacy Retail › Heavy Electrical Equipment
| ₹617.05 | 35.18 | 7,413 Cr | 3.75 | 0.00% | 11.12% | 12.20% | 7,306 Cr | 211 Cr | |
| ₹1,610.00 | 55.86 | 7,007 Cr | 4.17 | 0.00% | 8.32% | 11.61% | 7,144 Cr | 168 Cr | |
| — | 36.62 | 195 Cr | 2.97 | 0.00% | -26.40% | -26.06% | 5 Cr | 4 Cr | |
| Vijaypd Ceutical (this company) | ₹85.00 | — | 166 Cr | 3.16 | 0.00% | 9.54% | 14.15% | — | — |
| Median 4 companies | ₹617.05 | 36.62 | 3,601 Cr | 3.46 | 0.00% | 8.93% | 11.91% | 7,144 Cr | 168 Cr |
Comparable companies in the same industry. Market cap, P/E and P/B use the live price; other metrics are as reported in filings. A dash means the figure is not published for that company.
Tapetide Score
Data-driven rating, 0–100. How it works →
v2.0.0
Category scores
The Tapetide Score is data analysis, not investment advice. Tapetide is not a SEBI-registered research analyst or investment adviser.
Key Insights
Weaknesses
5- Though the company is reporting repeated profits, it is not paying out dividend
- Company might be capitalizing the interest cost
- Earnings include an other income of Rs.4.02 Cr.
- Debtor days have increased from 88.6 to 111 days.
- Working capital days have increased from 24.4 days to 64.7 days
Technical Indicators
Oscillators
Bullish
Overall
Bullish
Moving Averages
Bullish
Growth Rate
change over 1 year
change over 1 year
change over 1 year
Quarterly Results
| Particulars | Sep 2024 | Mar 2025 | Sep 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 50.32 | 49.91 | 51.33 | 47.62 |
| Expenses | 44.84 | 46.99 | 46.97 | 47.27 |
| Operating Profit | 5.48 | 2.92 | 4.36 | 0.35 |
| OPM % | 10.89% | 5.85% | 8.49% | 0.73% |
| Other Income | 0.01 | 0.75 | 0.32 | 3.7 |
| Interest | 1.17 | 0.98 | 1.06 | 0.53 |
| Depreciation | 0.3 | 0.31 | 0.28 | 0.34 |
| PBT | 4.02 | 2.38 | 3.34 | 3.18 |
| Tax % | 26.62% | 26.05% | 27.84% | 16.67% |
| Net Profit | 2.95 | 1.76 | 2.42 | 2.64 |
| EPS (₹) | 4.21 | 1.25 | 1.73 | 1.35 |
Profit & Loss
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Sales | 51.09 | 59.15 | 100 | 98.96 |
| Expenses | 49.77 | 54.27 | 91.8 | 94.25 |
| Operating Profit | 1.32 | 4.88 | 8.42 | 4.71 |
| OPM % | 2.58% | 8.25% | 8.4% | 4.76% |
| Other Income | 1.82 | 0 | 0.75 | 4.02 |
| Interest | 2.36 | 1.76 | 2.15 | 1.6 |
| Depreciation | 0.43 | 0.35 | 0.62 | 0.62 |
| PBT | 0.35 | 2.77 | 6.4 | 6.52 |
| Tax % | 48.57% | 40.43% | 26.41% | 22.39% |
| Net Profit | 0.18 | 1.65 | 4.71 | 5.06 |
| EPS (₹) | — | — | 3.36 | 2.59 |
| Div. Payout % | 0% | 0% | 0% | 0% |
Balance Sheet
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Equity Capital | 0 | 1 | 14.03 | 19.53 |
| Reserves | 4.93 | 5.59 | 18.39 | 33.01 |
| Borrowings | 25.57 | 24.45 | 21.77 | 33.67 |
| Other Liabilities | 2.37 | 2.23 | 3.09 | 10.1 |
| Total Liabilities | 32.87 | 33.27 | 57.28 | 96.31 |
| Fixed Assets | 2.73 | 2.43 | 8.74 | 8.72 |
| CWIP | 0 | 0 | 0.11 | 1.66 |
| Investments | 0.16 | 0.15 | 0.25 | 2.09 |
| Other Assets | 29.98 | 30.69 | 48.18 | 83.84 |
| Total Assets | 32.87 | 33.27 | 57.28 | 96.31 |
Cash Flow
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Operating | 0.3 | 2.93 | -34.5 | -7.32 |
| Investing | -0.09 | 12.78 | -9.72 | -12.17 |
| Financing | -0.18 | -1.86 | 47.32 | 25.37 |
| Net Cash Flow | 0.03 | 13.84 | 3.1 | 5.88 |
| Free Cash Flow | 0.28 | 2.87 | -43.97 | -9.46 |
| CFO/OP | 38 | 60 | -397 | -128 |
Ratios
| Particulars | Mar 2023 | Mar 2024 | Mar 2025 | Mar 2026 |
|---|---|---|---|---|
| Debtor Days | 62.44 | 68.56 | 86.68 | 111 |
| Inventory Days | 30.97 | 28.85 | 47.61 | 46.48 |
| Days Payable | 15.44 | 5.13 | 8.09 | 31.77 |
| Cash Conversion Cycle | 77.96 | 92.29 | 126 | 125 |
| Working Capital Days | -83.94 | -60.1 | 68.65 | 64.69 |
| ROCE % | — | 14.75% | 20.06% | 11.57% |
Insights
BetaAI-extracted from concalls & annual reports · figures as reported, with sources
Log in to view Vijaypd Ceutical insights
54 extracted metrics + investor summaries across FY23–FY26.
Documents
Frequently Asked Questions about Vijaypd Ceutical
What does Vijaypd Ceutical Ltd do?
Where is Vijaypd Ceutical Ltd (VIJAYPD) listed?
Which sector does Vijaypd Ceutical Ltd belong to?
What is the market capitalisation of Vijaypd Ceutical Ltd?
What is the 52-week high and low of Vijaypd Ceutical Ltd?
What is the Return on Equity (ROE) of Vijaypd Ceutical Ltd?
Company Information
Incorporated in October 1971, Vijaypd Ceutical Limited distributes pharmaceutical products and consumer goods, offering a comprehensive range of services.[1]
For AI agents and developers
Reading this as an AI agent, LLM or automated pipeline? Every page on Tapetide is also published as clean Markdown — no navigation, no scripts, just the data. Fetch https://tapetide.com/stocks/VIJAYPD.md for Vijaypd Ceutical Ltd: company profile, latest price, key fundamentals, the Tapetide Score, growth rates, quarterly and annual financial statements, shareholding pattern, technical indicators, analyst ratings and exchange filings.
Append .md to any Tapetide URL for the
same treatment. A full index of what we publish is at /llms.txt and /llms-full.txt. For
live, structured queries instead of documents, use our Indian stock market MCP server.